ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Valencia, VC, ESP:

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) (TroFuse-005)

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Doxorubicin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Valencia, Valenciana, Comunitat, Spain and 218 other locations

for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...

Active, not recruiting
Endometrial Cancer
Drug: Matching placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Valencia, Spain and 77 other locations

study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...

Enrolling
Endometrial Cancer
Drug: Carboplatin-Paclitaxel
Drug: Dostarlimab

Phase 3

ARCAGY/ GINECO GROUP

Valencia, Spain and 83 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Tesaro
Tesaro

Valencia, Spain and 162 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Doxorubicin
Drug: Paclitaxel

Phase 3

Eisai
Eisai

Valencia, Spain and 168 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Valencia, Valenciana, Comunitat, Spain and 73 other locations

This interventional study will evaluate the efficacy and safety of ART0380 as monotherapy in patients whose tumors have a biology to predict...

Enrolling
Metastatic Cancer
Recurrent Endometrial Cancer
Drug: ART0380

Phase 2

Artios Pharma

Valencia, Spain and 14 other locations

The purpose of this trial is to measure the following in participants with solid tumors who receive GEN1047:* The side effects seen with GEN...

Active, not recruiting
Endometrial Cancer, Endometrial Neoplasm
Squamous Non Small Cell Lung Cancer (NSCLC-SCC)
Biological: GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive tumor cells.

Phase 1, Phase 2

Genmab
Genmab

Valencia, Spain and 35 other locations

First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....

Enrolling
Endometrial Cancer
Advanced Solid Tumor
Drug: CPI-0209

Phase 1, Phase 2

Constellation Pharmaceuticals

Valencia, Spain and 59 other locations

farletuzumab ecteribulin (MORAb-202) in participants with selected tumor types (ovarian cancer \[OC\], endometrial cancer...

Enrolling
Solid Tumor
Drug: Prednisone
Drug: Farletuzumab ecteribulin

Phase 1, Phase 2

Eisai
Eisai

Valencia, Spain and 53 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems